You have 9 free searches left this month | for more free features.

EyePoint

Showing 1 - 18 of 18

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Wet Age-related Macular Degeneration Trial in United States (EYP-1901)

Completed
  • Wet Age-related Macular Degeneration
  • Phoenix, Arizona
  • +10 more
Jul 25, 2022

Wet Age-related Macular Degeneration Trial in United States (Eyp-1901, Aflibercept 2Mg/0.05Ml Inj,Oph)

Recruiting
  • Wet Age-related Macular Degeneration
  • Melbourne, Florida
  • +4 more
Aug 18, 2022

Cataract Trial in Palo Alto, Charleston (Dexamethasone, Prednisolone Acetate Ophthalmic)

Recruiting
  • Cataract
  • Palo Alto, California
  • +1 more
Jan 3, 2022

Uveitis, Uveitis, Posterior, Uveitis, Intermediate Trial in Waltham (Sham Injector, FAI Insert)

Active, not recruiting
  • Uveitis
  • +2 more
  • Sham Injector
  • FAI Insert
  • Waltham, Massachusetts
    EyePoint Study Site
Dec 20, 2022

Cataract Trial in Largo (Dexycu, Standard of Care post operative eye drops (steroid, antibiotic, NSAID))

Recruiting
  • Cataract
  • Dexycu
  • Standard of Care post operative eye drops (steroid, antibiotic, NSAID)
  • Largo, Florida
    The Eye Institute of West Florida
Mar 1, 2021

Diabetic Macular Edema Trial (EYP-1901, Aflibercept 2Mg/0.05Ml Inj,Oph)

Not yet recruiting
  • Diabetic Macular Edema
  • (no location specified)
Oct 19, 2023

Nonproliferative Diabetic Retinopathy Trial (EYP-1901, Sham IVT)

Not yet recruiting
  • Nonproliferative Diabetic Retinopathy
  • (no location specified)
Aug 3, 2022

Cataract Trial (Dexycu, Placebo/Vehicle)

Not yet recruiting
  • Cataract
  • (no location specified)
Sep 21, 2022

Uveitis, Posterior Trial in United States (Fluocinolone Acetonide Intravitreal Implant 0.18 mg)

Recruiting
  • Uveitis, Posterior
  • Fluocinolone Acetonide Intravitreal Implant 0.18 mg
  • Phoenix, Arizona
  • +16 more
Aug 18, 2022

Cataract Trial (Dexycu, Placebo/Vehicle)

Not yet recruiting
  • Cataract
  • (no location specified)
Sep 21, 2022

DEXYCU 9% Retrospective Study 001

Completed
  • Cataract
  • DEXYCU (dexamethasone intraocular suspension) 9%.
  • Dothan, Alabama
  • +21 more
May 24, 2021

Uveitis, Uveitis, Posterior, Uveitis, Anterior Trial in Plano (Yutiq 0.18 MG Drug Implant, Sham Injection)

Not yet recruiting
  • Uveitis
  • +3 more
  • Yutiq 0.18 MG Drug Implant
  • Sham Injection
  • Plano, Texas
    Texas Retina Associates
Aug 3, 2022

Imaging of Uveitis Patients Receiving Injectable Fluocinolone

Recruiting
  • Uveitis
  • Fluocinolone Acetonide
  • Cleveland, Ohio
    Cole Eye Institute Cleveland Clinic Foundation
Apr 27, 2022

Non-Infectious Uveitis Trial in Worldwide (FAI insert, Sham injection)

Completed
  • Non-Infectious Uveitis
  • FAI insert
  • Sham injection
  • Beverly Hills, California
  • +33 more
Mar 5, 2021

Posterior Uveitis, Intermediate Uveitis, Panuveitis Trial in India (Sham Injection, FAI Insert)

Completed
  • Posterior Uveitis
  • +2 more
  • Sham Injection
  • FAI Insert
  • Hyderabad, Andhra Pradesh, India
  • +14 more
Jul 10, 2020

Cataract Trial in Laguna Hills, Garden City (Dexycu intracameral dexamethasone, Prednisolone Acetate)

Completed
  • Cataract
  • Dexycu intracameral dexamethasone
  • Prednisolone Acetate
  • Laguna Hills, California
  • +1 more
Dec 9, 2020

Non-Infectious Uveitis Trial in United States (FAI Insert administered using the Mk II inserter, FAI Insert administered using

Completed
  • Non-Infectious Uveitis
  • FAI Insert administered using the Mk II inserter
  • FAI Insert administered using the Mk I inserter
  • Colorado Springs, Colorado
  • +5 more
Apr 22, 2020

Inflammatory Reaction Due to Ocular Lens Prosthesis Trial in Los Altos (IBI-10090)

Terminated
  • Inflammatory Reaction Due to Ocular Lens Prosthesis
  • Los Altos, California
    Altos Eye Physicians
Nov 6, 2018